Chile · Delayed Price · Currency is CLP SNSE:PLANVITAL Statistics
Total Valuation
SNSE:PLANVITAL has a market cap or net worth of CLP 494.90 billion. The enterprise value is 454.39 billion.
| Market Cap | 494.90B |
| Enterprise Value | 454.39B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
SNSE:PLANVITAL has 2.04 billion shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 2.04B |
| Shares Outstanding | 2.04B |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 23.78M |
Valuation Ratios
The trailing PE ratio is 8.16.
| PE Ratio | 8.16 |
| Forward PE | n/a |
| PS Ratio | 3.56 |
| PB Ratio | 3.41 |
| P/TBV Ratio | 3.63 |
| P/FCF Ratio | 9.99 |
| P/OCF Ratio | 9.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.58, with an EV/FCF ratio of 9.17.
| EV / Earnings | 7.49 |
| EV / Sales | 3.27 |
| EV / EBITDA | 5.58 |
| EV / EBIT | 5.73 |
| EV / FCF | 9.17 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.62 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.08 |
| Interest Coverage | 372.47 |
Financial Efficiency
Return on equity (ROE) is 47.33% and return on invested capital (ROIC) is 36.87%.
| Return on Equity (ROE) | 47.33% |
| Return on Assets (ROA) | 28.81% |
| Return on Invested Capital (ROIC) | 36.87% |
| Return on Capital Employed (ROCE) | 49.47% |
| Revenue Per Employee | 169.53M |
| Profits Per Employee | 74.06M |
| Employee Count | 862 |
| Asset Turnover | 0.82 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SNSE:PLANVITAL has paid 19.95 billion in taxes.
| Income Tax | 19.95B |
| Effective Tax Rate | 24.75% |
Stock Price Statistics
The stock price has increased by +47.56% in the last 52 weeks. The beta is 0.04, so SNSE:PLANVITAL's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +47.56% |
| 50-Day Moving Average | 213.45 |
| 200-Day Moving Average | 202.72 |
| Relative Strength Index (RSI) | 97.55 |
| Average Volume (20 Days) | 42,198 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNSE:PLANVITAL had revenue of CLP 138.84 billion and earned 60.66 billion in profits. Earnings per share was 29.78.
| Revenue | 138.84B |
| Gross Profit | 138.84B |
| Operating Income | 78.08B |
| Pretax Income | 80.60B |
| Net Income | 60.66B |
| EBITDA | 79.60B |
| EBIT | 78.08B |
| Earnings Per Share (EPS) | 29.78 |
Balance Sheet
The company has 44.51 billion in cash and 4.01 billion in debt, giving a net cash position of 40.51 billion or 19.89 per share.
| Cash & Cash Equivalents | 44.51B |
| Total Debt | 4.01B |
| Net Cash | 40.51B |
| Net Cash Per Share | 19.89 |
| Equity (Book Value) | 145.26B |
| Book Value Per Share | 71.32 |
| Working Capital | 19.69B |
Cash Flow
In the last 12 months, operating cash flow was 49.97 billion and capital expenditures -435.44 million, giving a free cash flow of 49.54 billion.
| Operating Cash Flow | 49.97B |
| Capital Expenditures | -435.44M |
| Free Cash Flow | 49.54B |
| FCF Per Share | 24.32 |
Margins
Gross margin is 100.00%, with operating and profit margins of 56.24% and 43.69%.
| Gross Margin | 100.00% |
| Operating Margin | 56.24% |
| Pretax Margin | 58.05% |
| Profit Margin | 43.69% |
| EBITDA Margin | 57.33% |
| EBIT Margin | 56.24% |
| FCF Margin | 35.68% |
Dividends & Yields
This stock pays an annual dividend of 13.22, which amounts to a dividend yield of 5.44%.
| Dividend Per Share | 13.22 |
| Dividend Yield | 5.44% |
| Dividend Growth (YoY) | -20.01% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.38% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 5.44% |
| Earnings Yield | 12.26% |
| FCF Yield | 10.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNSE:PLANVITAL has an Altman Z-Score of 8.09 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.09 |
| Piotroski F-Score | 4 |